Browsing: Wellness Tips

Himachal Pradesh has long been recognised for its pristine environment, physically active communities and traditional lifestyle patterns. However, the state is now witnessing a gradual but concerning rise in childhood obesity, creating a new public health challenge. The changing nature of childhood, marked by reduced physical activity, altered dietary patterns and increasing screen dependence, is…

Inspire360, the education technology powering leading fitness companies and health clubs, today announced the release of the Q2 2026 GLP-1 Club Intelligence Report. This edition tracks 23 fitness clubs and 12 solution providers taking concrete action in the GLP-1 space, up from 17 clubs and 10 providers in Q1

Kendra Wilkinson “couldn’t feel more amazing” about her bikini body as she continues her GLP-1 journey

After leading the Bears to the playoffs last season for the first time since 2020, Caleb Williams is expecting bigger things this year thanks in part to a change in his physique

AsMedifast, Inc.MED prepares to unveil its second-quarter fiscal 2026 results on Aug. 03, after market close, investors are eager to see if the company can beat market expectations

Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its blockbuster semaglutide-based (GLP-1) drugs — Ozempic (for type II diabetes [T2D]) and Wegovy (for obesity)

Rosie O’Donnell shared insight into her 60-lb weight loss transformation, revealing that she didn’t experience any adverse side effects from taking GLP-1 medication

Amgen(NASDAQ: AMGN) is betting that the convenience of its weight loss treatment will make it a winner, and it might be right. Its candidate MariTide is a monthly injection that aims to directly challenge the anti-obesity drugs made by Eli Lilly(NYSE: LLY) and Novo Nordisk(NYSE: NVO), which in their original formulations are administered by a…

Withings research finds that muscle-to-fat ratio at the start of treatment is the strongest predictor of both how much weight is lost on GLP-1 therapy and whether it comes from fat or muscle. The peer-reviewed, real-world study, published in Mayo Clinic Proceedings: Digital Health, followed 396 GLP-1 users and matched 1635 non-users using data from…

As the newly licensed Wegovy pill joins injectable GLP-1s on the UK market, primary care pharmacists are increasingly the first point of contact for patients navigating fasting — from Ramadan to dietary intermittent fasting. Advanced dietetic practitioner, Angela Carvalho, sets out how clinicians can advise patients safely and sensitively